Mirtazapine Teva

Mirtazapine, the active ingredient in Mirtazapine Teva, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as an oral tablet for oral use. It treats major depressive disorder in adult patients. GNH USA supplies Mirtazapine Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mirtazapine is indicated for the treatment of major depressive disorder, a mood disorder characterized by persistent low mood and loss of interest. - Major depressive disorder: alleviates depressive symptoms and improves mood in adults.

Mirtazapine may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Sedation: drowsiness, especially after initial doses. - Increased appetite: often leading to weight gain. - Dry mouth: reduced salivation. - Constipation: slowed gastrointestinal motility.

Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cells. - Hepatic dysfunction: abnormal liver enzymes. - Severe hypersensitivity: rash, swelling, or anaphylaxis. - Suicidal thoughts: emergence or worsening of suicidal ideation.

Before prescribing Mirtazapine, clinicians should consider several safety factors. - Assess hepatic function: adjust use in severe liver impairment. - Monitor weight: patients may experience significant weight gain. - Screen for suicidal ideation: especially during treatment initiation. - Caution in elderly: increased risk of sedation and falls. - Avoid abrupt discontinuation: taper dose to reduce withdrawal symptoms. - Store at ambient temperature: keep in original container, protect from moisture.

Mirtazapine can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Strong CYP2D6 inhibitors: may raise plasma mirtazapine levels. - CNS depressants: additive sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - Other antidepressants: potential for serotonin syndrome. - Antihistamines: may enhance sedative effects. - Alcohol: increases central nervous system depression.